Clinical Trial Update: Base-edited Autologous Hematopoietic Stem Cell Transplantation in Treating Patients With β-thalassemia Major [EARLY_Phase 1]

View source ↗

Summary

This is an early-phase (Phase 1) clinical trial evaluating base-edited autologous hematopoietic stem cell transplantation for beta-thalassemia major.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Beta Thalassemia Major

Drugs mentioned

• Base-edited autologous hematopoietic stem cell transplantation

Snippet

Sponsor: Children's Hospital of Fudan University | Conditions: Beta-Thalassemia | EARLY_Phase 1 | Status: ACTIVE_NOT_RECRUITING